Sensex
82,408.17 profit arw 1,046.30 (1.29%)
Nifty
25,112.40 profit arw 319.15 (1.29%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Refresh Captcha
Equity

As on : 10-Jun-2025
Corporate News
10-Jun-2025     14:11

Zydus receives EIR for the API manufacturing facility at Dabhasa

  Zydus Lifesciences has received the EIR report from the USFDA for the inspection conducted at its API manufacturing facility located at Dabhasa near Vadodara. This facility underwent an inspection from 21st to 25th April 2025 and has been classified as Voluntary Action Indicated (VAI). FDA confirmed the inspection as 'closed'.

 

Powered by Capital Market - Live News

INDIAN INDICES

Sensex

82,408.17 1,046.30 (1.29%)

Nifty

25,112.40 319.15 (1.29%)

GLOBAL INDICES

USD

85.75 0.06 (0.95%)

NASDAQ
HANG SENG

23,530.49 292.74(1.26%)